Sri Kosuri of Octant - The Future of Drugs, Synthetic Biology, and Complex Diseases

In this episode of Build The Future, we talk with Sri Kosuri, CEO & co-founder of Octant. At Octant they engineer biology to design multi-targeted small molecule drug leads to transform the treatment of society’s most complex diseases.  We talk about their drug discovery engine, engineering biology, genetics, advances in biotech, and much more!

Links Mentioned 

• Octant Launches Polypharmacology Drug Discovery Engine for Complex Diseases with $30 Million Series A Financing Led by Andreessen Horowitz article on biospace.com

To listen to more episodes and stay connected, follow along at:

• https://www.buildthefuturepodcast.com/
• https://twitter.com/camwiese

Don’t forget to leave a review and subscribe.
Have a great week and until next time, go build!

Thanks for joining us for this episode of the Build The Future Podcast!

Podcast Info:
Website: https://www.buildthefuturepodcast.com/
Apple Podcasts: https://podcasts.apple.com/us/podcast/build-the-future/id1516358690
Spotify: https://open.spotify.com/show/4gV7PsoAzDlil4jAKpSrYm
Youtube Full Episodes: https://www.youtube.com/@worldsfairco

Get in touch, recommend guests, or say hello:
X: https://twitter.com/camwiese
Email: podcast [at] worldsfair.co

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit camwiese.com